FDA reverses course on telework after layoffs and resignations threaten basic operations
By MATTHEW PERRONE
WASHINGTON (AP) — Weeks after ordering all Food and Drug Administration employees back into the office, the agency is reversing course, allowing some of its most prized staffers to work remotely amid worries that recent layoffs and resignations could jeopardize basic functions, like approving new medicines.
Related Articles
-
Trump wants Congress to end the changing of clocks and keep the country on daylight saving time -
Schools lined up for help getting cleaner school buses. Then came the EPA freeze -
Iowa Republican Gov. Kim Reynolds announces she won’t seek reelection in 2026 -
The House speaker’s eyeing big cuts to Medicaid. In his Louisiana district, it’s a lifeline -
Trump administration to refer Maine to Justice Department over transgender participation in sports
An internal email obtained by The Associated Press states that FDA leadership are “allowing review staff and supervisors to resume telework” at least two days a week. The policy shift was confirmed by three FDA staffers who spoke to the AP on the condition of anonymity to discuss internal agency matters.